Skip to main content

Osteopontin polymorphisms and disease course in multiple sclerosis.

Publication ,  Journal Article
Caillier, S; Barcellos, LF; Baranzini, SE; Swerdlin, A; Lincoln, RR; Steinman, L; Martin, E; Haines, JL; Pericak-Vance, M; Hauser, SL ...
Published in: Genes Immun
June 2003

Osteopontin (OPN), also known as early T-cell activating gene (Eta-1), has been recently shown to be a critical factor in the progression of experimental autoimmune encephalomyelitis, and perhaps multiple sclerosis (MS). Here we investigated whether the 327T/C, 795C/T, 1128A/G or 1284A/C single-nucleotide polymorphisms in the OPN gene were correlated with susceptibility or any of the several clinical end points in a cohort of 821 MS patients. Overall, we observed no evidence of genetic association between the OPN polymorphisms and MS. Although not reaching statistical significance, a modest trend for association with disease course was detected in patients carrying at least one wild-type 1284A allele, suggesting an effect on disease course. Patients with this genotype were less likely to have a mild disease course and were at increased risk for a secondary-progressive clinical type.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Genes Immun

DOI

ISSN

1466-4879

Publication Date

June 2003

Volume

4

Issue

4

Start / End Page

312 / 315

Location

England

Related Subject Headings

  • Sialoglycoproteins
  • Polymorphism, Genetic
  • Osteopontin
  • Odds Ratio
  • Multiple Sclerosis, Chronic Progressive
  • Multiple Sclerosis
  • Male
  • Immunology
  • Humans
  • Genotype
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Caillier, S., Barcellos, L. F., Baranzini, S. E., Swerdlin, A., Lincoln, R. R., Steinman, L., … Multiple Sclerosis Genetics Group, . (2003). Osteopontin polymorphisms and disease course in multiple sclerosis. Genes Immun, 4(4), 312–315. https://doi.org/10.1038/sj.gene.6363952
Caillier, S., L. F. Barcellos, S. E. Baranzini, A. Swerdlin, R. R. Lincoln, L. Steinman, E. Martin, et al. “Osteopontin polymorphisms and disease course in multiple sclerosis.Genes Immun 4, no. 4 (June 2003): 312–15. https://doi.org/10.1038/sj.gene.6363952.
Caillier S, Barcellos LF, Baranzini SE, Swerdlin A, Lincoln RR, Steinman L, et al. Osteopontin polymorphisms and disease course in multiple sclerosis. Genes Immun. 2003 Jun;4(4):312–5.
Caillier, S., et al. “Osteopontin polymorphisms and disease course in multiple sclerosis.Genes Immun, vol. 4, no. 4, June 2003, pp. 312–15. Pubmed, doi:10.1038/sj.gene.6363952.
Caillier S, Barcellos LF, Baranzini SE, Swerdlin A, Lincoln RR, Steinman L, Martin E, Haines JL, Pericak-Vance M, Hauser SL, Oksenberg JR, Multiple Sclerosis Genetics Group. Osteopontin polymorphisms and disease course in multiple sclerosis. Genes Immun. 2003 Jun;4(4):312–315.

Published In

Genes Immun

DOI

ISSN

1466-4879

Publication Date

June 2003

Volume

4

Issue

4

Start / End Page

312 / 315

Location

England

Related Subject Headings

  • Sialoglycoproteins
  • Polymorphism, Genetic
  • Osteopontin
  • Odds Ratio
  • Multiple Sclerosis, Chronic Progressive
  • Multiple Sclerosis
  • Male
  • Immunology
  • Humans
  • Genotype